Literature DB >> 25833160

Effects of hemoadsorption with a novel adsorbent on sepsis: in vivo and in vitro study.

Jicheng Zhang1, Zhiyong Peng, Donald Maberry, Jacob Volpe, Jeremy D Kimmel, William J Federspiel, John A Kellum.   

Abstract

BACKGROUND/AIMS: Hemoadsorption may improve outcomes for sepsis by removing circulating cytokines. We tested a new sorbent used for hemoadsorption.
METHODS: CTR sorbent beads were filled into columns of three sizes: CTR0.5 (0.5 ml), CTR1 (1.0 ml) and CTR2 (2.0 ml) and tested using IL-6 capture in vitro. Next, rats were subjected to cecal ligation and puncture and randomly assigned to hemoadsorption with CTR0.5, CTR1, CTR2 or sham treatment. Plasma biomarkers were measured.
RESULTS: In vitro, IL-6 removal was accelerated with increasing bead mass. In vivo, TNF, IL-6, IL-10, high mobility group box1, and cystatin C were significantly lower 24 h after CTR2 treatment. Seven-day survival rate was 50, 64, 63, and 73% for the sham, CTR0.5, CTR1, CTR2, respectively.
CONCLUSION: CTR appeared to have a favorable effect on kidney function despite no immediate effects on cytokine removal. However, CTR2 beads did result in a late decrease of cytokines.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833160      PMCID: PMC4399745          DOI: 10.1159/000381006

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  23 in total

1.  Extracorporeal removal for sepsis: Acting at the tissue level--the beginning of a new era for this treatment modality in septic shock.

Authors:  Patrick M Honoré; James R Matson
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

2.  Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia.

Authors:  John A Kellum; Mingchen Song; Ramesh Venkataraman
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

Review 3.  Pathophysiology of sepsis.

Authors:  Judith Jacobi
Journal:  Am J Health Syst Pharm       Date:  2002-02-15       Impact factor: 2.637

4.  High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research.

Authors:  P M Honore; O Joannes-Boyau
Journal:  Int J Artif Organs       Date:  2004-12       Impact factor: 1.595

Review 5.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

6.  Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.

Authors:  Zhi-Yong Peng; Melinda J Carter; John A Kellum
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

7.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

Authors:  John A Kellum; Lan Kong; Mitchell P Fink; Lisa A Weissfeld; Donald M Yealy; Michael R Pinsky; Jonathan Fine; Alexander Krichevsky; Russell L Delude; Derek C Angus
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

8.  A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia.

Authors:  Takumi Taniguchi; Fumiyasu Hirai; Yasuhiro Takemoto; Kazunobu Tsuda; Ken Yamamoto; Hideo Inaba; Hiroshi Sakurai; Shigeo Furuyoshi; Nobutaka Tani
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

9.  Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Authors:  Thomas Rimmelé; Ata Murat Kaynar; Joseph N McLaughlin; Jeffery V Bishop; Morgan V Fedorchak; Anan Chuasuwan; Zhiyong Peng; Kai Singbartl; Daniel R Frederick; Lin Zhu; Melinda Carter; William J Federspiel; Adriana Zeevi; John A Kellum
Journal:  Crit Care       Date:  2013-03-26       Impact factor: 9.097

10.  Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats.

Authors:  John A Kellum; Michael K Dishart
Journal:  Crit Care       Date:  2002-06-19       Impact factor: 9.097

View more
  3 in total

1.  Antibody-modified conduits for highly selective cytokine elimination from blood.

Authors:  J Brian McAlvin; Ryan G Wylie; Krithika Ramchander; Minh T Nguyen; Charles K Lok; Morgan Moroi; Andre Shomorony; Nikolay V Vasilyev; Patrick Armstrong; Jason Yang; Alexander M Lieber; Obiajulu S Okonkwo; Rohit Karnik; Daniel S Kohane
Journal:  JCI Insight       Date:  2018-07-12

2.  A Novel Pathogen Capturing Device for Removal and Detection.

Authors:  Gwangseong Kim; Horatiu Vinerean; Angelo Gaitas
Journal:  Sci Rep       Date:  2017-07-17       Impact factor: 4.379

3.  Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer.

Authors:  Vitaliy Sazonov; Ramazan Abylkassov; Zaure Tobylbayeva; Askhat Saparov; Olga Mironova; Dimitri Poddighe
Journal:  Front Pediatr       Date:  2021-06-11       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.